UPADACITINIB (upadacitinib) by Aurobindo Pharma is janus kinase inhibitors [moa].
Drug data last refreshed 18h ago
Janus Kinase Inhibitors
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
A Study to Learn How Effective, Safe, and Tolerable Upadacitinib is for Young Participants With Non-segmental Vitiligo
Upadacitinib in Patients Hospitalized With Acute Severe Ulcerative Colitis
Upadacitinib in Treatment of JAK/STAT Pathway Disorders With Activating Mutations
Effectiveness of Upadacitinib and Biologics for the Achievement of Minimal Disease Activity in Adults With Moderate-to-Severe Atopic Dermatitis (RAMpUp)
A Trial of Upadacitinib for Non-responsive Eosinophilic Esophagitis
Worked on UPADACITINIB at Aurobindo Pharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.